Heather Hampel
@HHampel1
Cancer Genetic Counselor; Associate Director, Division of Clinical Cancer Genomics; City of Hope National Medical Center.
Despite clear guidelines, germline genetic testing remains underutilized in patients with metastatic breast cancer. In our new study published in JCO Precision Oncology, we evaluated >15,000 patients with metastatic breast cancer and found that fewer than half received germline…
#ASCO25: City of Hope is nationally recognized for its leadership in hereditary cancer risk assessment, genetic testing, and personalized prevention strategies. @HHampel1 shares how this work is improving outcomes for patients and families — now and for generations to come.
Novel cancer associations from the UK biobank data presented by Dr. Joe Liu in the session I co-chaired this morning at @ASCO - BAP1 and breast, LZTR1 and GBM, DDX41 and ovarian, BRCA2 and lung, BRCA1/2 and endometrial. Generated a lot of discussion. @cityofhope
Finally chose the right shoes for ASCO - and I wasn’t the only one! Able to walk miles through McCormick comfortably. @sorelfootwear #ASCO2025
Amazing little science experiment with flavored sodas at the @cityofhope @ASCO booth! #ASCO2025
Agreed. In 2025, MSI and MMR IHC should be used to decide who gets immune checkpoint blockade therapy - not to decide who gets germline genetic testing.
"...our results do not support any tumor triage method...we recommend #universal #germlinetesting for all newly diagnosed #patients w/ #CRC..." Abu-Ghazaleh et al. Studies performing #universal #germlinetesting on all #patients w/ #CRC found 5.1% prevalence of #Lynchsyndrome…
A match made in cancer genetics heaven.
📢We're delighted to announce our partnership with the @cityofhope Clinical Cancer Genomics Community of Practice (CCGCOP) ➡️Through our 🤝we hope to enhance 🎓learning & provide 🔬collaborative opportunities to advance the science & clinical management of #HereditaryGICancer…
It was so great presenting about updates to the HBOP & HCEG guidelines with @LeemayChen1 , Tuya Pal, Kara Maxwell, & Xavier Llor last weekend at the @NCCN annual meeting.
Appreciate the attention to Gyn Onc updates in #endometrial cancer risk, #cervical cancer management, and #ovarian cancer management at the @NCCN Annual Conference. A trifecta of gyn medical oncologists took the stage this morning! #NCCN2025 #LynchSyndrome
Appreciate the attention to Gyn Onc updates in #endometrial cancer risk, #cervical cancer management, and #ovarian cancer management at the @NCCN Annual Conference. A trifecta of gyn medical oncologists took the stage this morning! #NCCN2025 #LynchSyndrome
Kathryn Reyes presenting alternative service delivery models at the @cityofhope Cancer Genomics Bootcamp.
Katherine Roth presenting the OncoKB timeline of approved molecular targeted therapies for cancer since 1998. @cityofhope
Jill Bates presenting about pharmacogenomics as one piece of the puzzle in treating cancer patients safely & effectively at the @cityofhope Cancer Genomics Bootcamp. Would love to see more institutions implement DPYD testing before 5-FU therapy.
Ravi Sharaf presenting the bottom line about the use of Multi-Cancer Detection tests for cancer screening at the @cityofhope Cancer Genetics Bootcamp.
Steve Gruber giving the welcome address at the @cityofhope Cancer Genetics Bootcamp.
Join the California Colorectal Cancer Coalition 5K in Mission Bay, CA on March 29, 2025. #colorectalcancer @CGAIGC
#ColorectalCancerAwarenessMonth starts on March 1 with #DressinBlueDay‼️ No matter what your role is in the #HereditaryGICancer community, wear blue & help raise awareness for everything related to #colorectalcancer‼️
Kathy Blazer welcoming everyone to the first in-person City of Hope Intensive Course in Cancer Risk Assessment since 2019. @cityofhope
